Alpha Wave Global LP Invests $17.17 Million in Masimo Corporation $MASI

Alpha Wave Global LP acquired a new position in shares of Masimo Corporation (NASDAQ:MASI) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 102,068 shares of the medical equipment provider’s stock, valued at approximately $17,170,000. Masimo makes up approximately 1.9% of Alpha Wave Global LP’s holdings, making the stock its 8th biggest position. Alpha Wave Global LP owned 0.19% of Masimo as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of MASI. Twin Tree Management LP bought a new position in shares of Masimo during the 1st quarter worth approximately $29,000. MAI Capital Management grew its holdings in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 129 shares in the last quarter. Hilltop National Bank acquired a new stake in shares of Masimo in the second quarter valued at about $37,000. Anderson Financial Strategies LLC acquired a new stake in shares of Masimo in the first quarter valued at about $49,000. Finally, Allworth Financial LP raised its holdings in Masimo by 72.8% during the second quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 163 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Up 3.0%

Masimo stock opened at $142.26 on Friday. The company’s 50-day moving average price is $145.85 and its two-hundred day moving average price is $151.97. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69. The stock has a market cap of $7.64 billion, a P/E ratio of -13.50, a P/E/G ratio of 1.60 and a beta of 1.26. Masimo Corporation has a twelve month low of $133.70 and a twelve month high of $194.88.

Masimo (NASDAQ:MASI) last posted its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 EPS for the quarter. The company had revenue of $617.00 million for the quarter. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%. As a group, analysts expect that Masimo Corporation will post 4.1 EPS for the current year.

Analysts Set New Price Targets

MASI has been the subject of a number of analyst reports. Bank of America initiated coverage on Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 price target for the company. Zacks Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research report on Monday. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company lowered their price objective on shares of Masimo from $190.00 to $187.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $188.80.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.